Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial.
Elife
; 112022 07 05.
Article
in En
| MEDLINE
| ID: mdl-35787784
Full text:
1
Database:
MEDLINE
Main subject:
Thiazoles
/
Lymphatic Abnormalities
/
Class I Phosphatidylinositol 3-Kinases
/
GTP Phosphohydrolases
/
Lymphangioma
/
Membrane Proteins
/
Antineoplastic Agents
Language:
En
Journal:
Elife
Year:
2022
Type:
Article
Affiliation country:
United States